On 28 February 1998, gastroenterologist Andrew Wakefield stood before cameras at London’s Royal Free Hospital and told the public that the measles-mumps-rubella (MMR) vaccine should be given as three separate jabs, citing a Lancet paper he had co-authored on twelve children. The paper itself never claimed to prove that MMR caused autism — its discussion section explicitly conceded “We did not prove an association between measles, mumps, and rubella vaccine and the syndrome described.” The promise of the press conference and the reality of the data were therefore divorced from the first day: a hypothesis dressed as a finding, a twelve-patient case series dressed as a public-health alarm. The gap would be measured, over the following two decades, in collapsed vaccination rates, returned outbreaks of an eliminated disease, and at least one young man dead of measles pneumonia in a country that had not recorded such a death in years.
The paper, titled “Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children,” survived twelve years as a live citation before it was fully retracted by The Lancet on 2 February 2010, and its lead author was erased from the UK medical register on 24 May 2010. What the intervening investigation — driven not by a regulator but by Sunday Times journalist Brian Deer — established was not honest error but fabrication. Of the twelve children’s case histories, not one matched the medical records cleanly; histopathology reported in the paper as “non-specific colitis” had in several cases been recorded as normal or unremarkable by the Royal Free’s own pathologists and altered upstream toward a diagnosis the thesis required. Children whose regression the paper timed to the days after vaccination had records placing the onset before the jab, or months after it.
The motive was financial and concealed. Wakefield had been paid £435,643, plus a £55,000 grant, via solicitor Richard Barr and the UK Legal Aid Board to find evidence for a planned class-action lawsuit against vaccine manufacturers — a conflict disclosed to no one, while several of the “consecutively referred” children were in fact litigation clients recruited through an anti-MMR campaign rather than ordinary clinical referrals. The retainer predated publication by roughly two years. A study presented as the disinterested observation of a treating physician was, beneath its surface, a brief assembled for paying counsel.
The cost was not abstract. UK MMR uptake fell from roughly 92% in 1995 to about 80% by 2003, dropping below 60% in parts of London — well under the ~95% threshold for herd immunity. Measles, declared eliminated in the UK in the 1990s, returned. The 2012–13 Swansea epidemic produced over 1,200 notified cases, 88 hospitalisations, and the death of a 25-year-old man, Gareth Williams, on 18 April 2013. Wakefield’s claim was not merely unproven; multiple large epidemiological studies covering millions of children — including a Danish cohort of more than 537,000 — found no association whatsoever. This dossier records “Overturned” entry TH-001 as the archetype of the withdrawn: a single twelve-patient paper, amplified by press conference and tabloid, that outran every safeguard in science publishing, peer review, and medical regulation, and was reversed only after a journalist did the work the institutions had not.
In the second week of September 1854, John Snow — a London anaesthetist with no laboratory, no microscope finding to show, and no theory the medical establishment accepted — presented the Board of Guardians of St James parish with a hand-drawn map of Soho on which 616 cholera deaths clustered, dot by dot, around a single public water pump on Broad Street, and asked them to remove its handle. The dominant explanation of disease at that moment was more than two millennia old: cholera, plague, malaria and the rest were held to arise from miasma, a poisonous “bad air” exhaled by rotting matter, sewage and stagnant filth. The gap between that doctrine and the dead of Soho was the entire case. The smell hanging over the district was real; the doctrine read it backward. The filth was not poisoning the air — it was leaking, through a cracked cesspit three feet from the well, into the water the neighbourhood drank.
Miasma theory was not a fringe error or a quack’s product. It was the consensus of educated medicine from Hippocrates and Galen through the Victorian sanitary movement, embedded in the architecture of cities, the design of hospitals, and the statutes of public health. The promise of the doctrine was coherence — it explained why disease concentrated in the poorest, foulest, lowest-lying districts. The reality it obscured was the transmission route: contaminated water and, beneath that, a living organism. The cost of the gap was counted in cholera epidemics that swept Britain in 1831–32, 1848–49, 1853–54 and 1866, killing tens of thousands while the responsible institutions fought the smell instead of the supply.
The reversal anchored to Broad Street was neither immediate nor clean. The epidemic was already subsiding when the handle came off on 8 September 1854; Snow himself conceded the attack had peaked days earlier. The parish authorities replaced the handle once the danger passed and rejected his theory. What 1854 produced was not a cure but the first rigorous demonstration that cholera moved through water, not air — reinforced by Snow’s “Grand Experiment” across South London, where homes served by the sewage-fouled Southwark and Vauxhall company died at roughly fourteen times the rate of those served by the cleaner Lambeth supply. Three decades later Robert Koch isolated the comma-shaped bacterium in Calcutta, and the bad air was finally, permanently displaced by the germ.
“Overturned” files this as TH-003 because miasma is the archetype of the displaced idea rather than the fraudulent one: a sincere, universal, internally consistent theory that was simply wrong about mechanism, that resisted its own disproof for a full generation after the decisive evidence arrived, and that yielded only when a confirmed organism replaced the speculative vapour.
On the pages of The New England Journal of Medicine in 1967, three Harvard nutrition scientists — Robert McGandy, D. Mark Hegsted, and department chair Fredrick Stare — published a two-part review, “Dietary Fats, Carbohydrates and Atherosclerotic Vascular Disease,” that declared there was “no doubt” the only dietary change needed to prevent coronary heart disease was to cut saturated fat and cholesterol. What the review did not say, and what its readers could not know, was that it had been commissioned, paid for, and editorially steered by the Sugar Research Foundation, the sugar industry’s trade body, which had set the review’s objective in advance precisely to deflect a rising scientific suspicion that its own product — sucrose — drove heart disease. The promise was an authoritative, disinterested survey of the evidence; the reality was a literature review with a sponsor who had already approved the answer.
The mechanism was exposed nearly half a century later. In September 2016, UCSF researchers Cristin Kearns, Laura Schmidt, and Stanton Glantz published an analysis in JAMA Internal Medicine of more than 340 industry documents totaling 1,582 pages. The papers showed that the Sugar Research Foundation paid the authors roughly $6,500 — about $48,000–$50,000 in 2016 dollars — under the codename “Project 226,” supplied the articles to be reviewed, defined the objective, and read drafts. The foundation’s vice-president for research, John Hickson, told the authors his interest lay in answering claims “that carbohydrates in the form of sucrose make an inordinate contribution,” and wrote that he would be “disappointed if this aspect is drowned out.” On 2 November 1966 Hickson pronounced a draft “quite what we had in mind.” None of this appeared in the published paper.
The cost was not a single bad study but a generation of misdirected emphasis. The NEJM at the time required no conflict-of-interest disclosure, so the review entered the literature as neutral science and helped anchor a five-decade national focus on dietary fat while sugar’s cardiometabolic role went comparatively under-investigated. Hegsted later became a key architect of U.S. federal dietary guidance, including the 1977 Dietary Goals for the United States. The findings were never formally retracted — the review remains in the record — but its evidentiary standing collapsed once the funding and editorial control were documented.
This dossier records “Overturned” entry TH-005 as the archetype of the captured review: not a forged dataset but a curated one, in which the harm was the silent purchase of a conclusion and the institutional norm — no disclosure required — that let the purchase pass as scholarship for forty-nine years.